The main method employed with tumor infiltrating lymphocytes (TILs) is an adoptive cell therapy, which consists of extracting lymphocytes from the tumor place and culture them in vitro while adding different stimuli, such as IL-2, and finally infusing them in the same patient (autologous treatment) [17]. This evidence concerns the gene IL2 and neoplasm.